Becker's Healthcare June 23, 2022
Naomi Diaz

Biotech company Fujifilm Irvine Scientific acquired Brigham and Women’s Hospital and Massachusetts General Hospital’s AI-based technology used to improve the success rate of in-vitro fertilization.

The technology, developed and patented jointly by investigators from Brigham and Women’s Hospital and Massachusetts General Hospital, both based in Boston, uses AI for image-based evaluation of human embryos in order to improve in-vitro fertilization success rates, according to a June...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

Continue Reading

 
Topics: AI (Artificial Intelligence), Biotechnology, Health System / Hospital, Mergers & Acquisitions / JV, Pharma / Biotech, Provider, Technology, Trends
Related Articles:
Boehringer signs $1.3B deal with RNA biotech Ochre Bio to team up against MASH
Bristol Myers taps startup to boost cell therapy production
With $380M deal, Bristol Myers Squibb ups the ante with cell therapy manufacturer Cellares
Boehringer Ingelheim Strikes Regenerative Med R&D Deal Spanning MASH & More Liver Diseases
Metsera Launches with $290M to Develop Next Generation Weight Loss Products

Share This Article